Therapeutic potential of low dose ionizing radiation against cancer, dementia, and diabetes: evidences from epidemiological, clinical, and preclinical studies
- 3 January 2023
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 50 (3) , 2823-2834
Abstract
The growing use of ionizing radiation (IR)-based diagnostic and treatment methods has been linked to increasing chronic diseases among patients and healthcare professionals. However, multiple factors such as IR dose, dose-rate, and duration of exposure influence the IR-induced chronic effects. The predicted links between low-dose ionizing radiation (LDIR) and health risks are controversial due to the non-availability of direct human studies. The studies pertaining to LDIR effects have importance in public health as exposure to background LDIR is routine. It has been anticipated that data from epidemiological and clinical reports and results of preclinical studies can resolve this controversy and help to clarify the notion of LDIR-associated health risks. Accumulating scientific literature shows reduced cancer risk, cancer-related deaths, curtailed neuro-impairments, improved neural functions, and reduced diabetes-related complications after LDIR exposure. In addition, it was found to alter evolutionarily conserved stress response pathways. However, the picture of molecular signaling pathways in LDIR responses is unclear. Besides, there is limited/no information on biomarkers of epidemiological LDIR exposure. Therefore, the present review discusses epidemiological, clinical, and preclinical studies on LDIR-induced positive effects in three chronic diseases (cancer, dementia, and diabetes) and their associated molecular mechanisms. The knowledge of LDIR response mechanisms may help to devise LDIR-based therapeutic modalities to stop disease progression. Modulation of these pathways may be helpful in developing radiation resistance among humans. However, more clinical evidence with additional biochemical, cellular, and molecular data and exploring the side effects of LDIR are the major areas of future research.Keywords
Funding Information
- Indian Council of Medical Research (36/8/2020/TOXI/BMS)
- Council of Scientific and Industrial Research, IN (09/1257(0001)/2019-EMR-I)
This publication has 91 references indexed in Scilit:
- Evidence Supporting Radiation Hormesis in Atomic Bomb Survivor Cancer Mortality DataDose-Response, 2012
- Hormesis: why it is important to biogerontologistsBiogerontology, 2012
- Cancer Mortality for a Single Race in Low Versus High Elevation Counties in the U.S.Dose-Response, 2010
- Attenuation of diabetes-induced renal dysfunction by multiple exposures to low-dose radiation is associated with the suppression of systemic and renal inflammationAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Low-Dose Radiation Does Not Induce Proliferation in Tumor CellsIn VitroandIn VivoRadiation Research, 2008
- Amelioration of Type II Diabetes indb/dbMice by Continuous Low-Dose-Rate γ IrradiationRadiation Research, 2007
- Effects of Cobalt-60 Exposure on Health of Taiwan Residents Suggest New Approach Needed in Radiation ProtectionDose-Response, 2007
- Low Dose γ-Rays Activate Immune Functions via Induction of Glutathione and Delay Tumor GrowthJournal of Radiation Research, 2004
- Gene expression changes in mouse brain after exposure to low‐dose ionizing radiationInternational Journal of Radiation Biology, 2003
- Prevention of Type I Diabetes by Low-Dose Gamma Irradiation in NOD MiceRadiation Research, 2000